Leukemia
ImmunotherapyLeukemiaLymphomaPersonalized Medicine
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Leukemia
Here are the drugs and financial support services available to patients receiving treatment for Leukemia.
Leukemia
By Dana Taylor
New findings show that starting with a targeted therapy regimen instead of chemotherapy improves outcomes for patients with chronic lymphocytic leukemia, particularly for those under age 70.
Genetics & CancerLeukemia
Knowing if the patient’s chronic lymphocytic leukemia (CLL) has genetic abnormalities through genetic testing can help doctors select the best treatment.
FDA Approvals, News & UpdatesLeukemiaNewsworthy
In July 2018, the FDA approved Tibsovo (ivo-sidenib; from Agios Pharmaceuticals), the first IDH1 inhibitor, for the treatment of adults with relapsed (returning) or refractory (not responding to treatment) acute myeloid leukemia (AML) and a susceptible IDH1 genetic mutation.
Family MembersLeukemiaPediatric Cancer
After his father’s diagnosis of acute lymphoblastic leukemia, 10-year-old Rhett is determined to become an oncologist to help other patients with cancer.
Leukemia
CLL is difficult to diagnose, because the symptoms only manifest in the later stages of the disease. As in all types of care, a late diagnosis often means worse prognosis.
CONQUER CamLeukemiaPatient Stories
Joyce Beecher vividly recounts her cancer journey as a caregiver to her husband, Rich Beecher, who was diagnosed with chronic lymphocytic leukemia (CLL) in 2003. Listen to Joyce’s story as she describes their determination to find the best care and treatment for Rich, and encourages patients and caregivers to never give up.
CONQUER CamLeukemiaPatient Stories
Diagnosed in 2003, Rich Beecher has been living with chronic lymphocytic leukemia (CLL) for 15 years. Rich describes his cancer journey – from “Why me?” to focusing on the positive things in his life, including immersing himself more in photography.
Leukemia
New therapies that are now available for people with this type of cancer have fewer side effects than traditional chemotherapy and can improve survival and quality of life.